Purchase Order 36C25621P0446
Award Date 1/13/21
Potential Completion Date 12/31/21
Potential Value $437K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New Orleans, LA 70119, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Vela Diagnostics USA Inc. to provide COVID-19 VELA TESTING REAGENTS AND CONSUMABLES. The contract, with a potential value of $184,029.47, has a completion date of June 25, 2021 and was awarded on June 11, 2020. This award, which did not have a set-aside, was made in support of the Coronavirus COVID-19 national interest action. Vela Diagnostics USA Inc. is a for-profit organization...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to Vela Diagnostics USA Inc., a for-profit organization, for the provision of laboratory testing equipment. The contract has a total small business set-aside designation and a potential value of $149,000.00. It supports the national interest action code for the Coronavirus COVID-19 response. Through past prime federal contract awards,...
- The U.S. Department of Veterans Affairs awarded a firm-fixed-price purchase order to Vela Diagnostics USA Inc. for the delivery of SARS-CoV-2 test reagents. The contract, valued at $86,922.21, has an ultimate completion date of October 8, 2021. Vela Diagnostics USA Inc. is a for-profit organization that has previously provided equipment rental, reagents, consumables, and research and development to support COVID-19 testing, HIV genotyping, and next-generation sequencing systems for various...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Vela Diagnostics USA Inc., a for-profit organization, to provide viral next-generation sequencing (NGS) testing for genotyping and resistance of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) at a cost of $148,104.85. The contract, which was not set aside, has a completion date of September 30, 2022. Vela Diagnostics USA Inc. has previously provided federal agencies,...
- The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a firm-fixed-price contract to Vela Diagnostics USA Inc. for the research and development of a probe-based reverse transcriptase polymerase chain reaction (RT-PCR) test for COVID-19. The contract, which was not set aside, has a potential value of $224,780 and a completion date of October 31, 2020. Vela Diagnostics USA Inc. is a global provider of integrated molecular...
- The Defense Health Agency awarded a $1.44 million firm fixed-price purchase order to Vela Diagnostics USA Inc. on September 20, 2021, for the lease of FDA-approved Vela Sentosa Next Generation Sequencing systems to support human immunodeficiency virus (HIV) genotyping and drug resistance monitoring for military members and their beneficiaries. The contract, which extends through September 29, 2026, will be performed at the contractor's facility in Fairfield, New Jersey. No set-aside...
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. to provide maintenance services for the Sentosa SQ HIV genotyping systems. The contract has a potential value of $100,000.00 and a period of performance ending on September 29, 2027. Vela Diagnostics USA Inc. is a global provider of integrated molecular diagnostic solutions that has previously supported federal agencies such as the Department of Veterans...
- This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, provides instrumentation and supplies for COVID-19 diagnostic testing. The $148,585 delivery order was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration and is not set aside. Cepheid is the prime contractor and will deliver COVID-19 testing equipment, reagents, and consumables to support the VA's clinical diagnostic programs. As the original equipment...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract is an Indefinite Delivery, Indefinite Quantity (IDIQ) for reagents, with a total potential value of $515,758.44. It was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 9. The contract is not set aside and is under the VA's Invitro...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded a delivery order to Diasorin Molecular LLC, a for-profit manufacturer of medical diagnostics, for the provision of COVID-19 tests. The $173,516.52 firm-fixed price contract does not have a set-aside designation and was issued under an existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract by VA's Veterans Integrated Service Network (VISN) 23. Diasorin Molecular, which is a foreign-owned company, has...